Related Experiment Video
Updated: Jan 4, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
Kerryn Berndsen1, Pawel Lis1, Wondwossen M Yeshaw2
1MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Abstract:
Mutations that activate LRRK2 protein kinase cause Parkinson's disease. LRRK2 phosphorylates a subset of Rab GTPases within their Switch-II motif controlling interaction with effectors. An siRNA screen of all human protein phosphatases revealed that a poorly studied protein phosphatase, PPM1H, counteracts LRRK2 signaling by specifically dephosphorylating Rab proteins. PPM1H knockout increased endogenous Rab phosphorylation and inhibited Rab dephosphorylation in human A549 cells. Overexpression of PPM1H suppressed LRRK2-mediated Rab phosphorylation. PPM1H also efficiently and directly dephosphorylated Rab8A in biochemical studies. A "substrate-trapping" PPM1H mutant (Asp288Ala) binds with high affinity to endogenous, LRRK2-phosphorylated Rab proteins, thereby blocking dephosphorylation seen upon addition of LRRK2 inhibitors. PPM1H is localized to the Golgi and its knockdown suppresses primary cilia formation, similar to pathogenic LRRK2. Thus, PPM1H acts as a key modulator of LRRK2 signaling by controlling dephosphorylation of Rab proteins. PPM1H activity enhancers could offer a new therapeutic approach to prevent or treat Parkinson's disease.
Insights
Protein phosphatase PPM1H dephosphorylates Rab proteins, counteracting LRRK2 signaling implicated in Parkinson's disease. Enhancing PPM1H activity may offer new therapeutic strategies for Parkinson's disease.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Mutations in Leucine-rich repeat kinase 2 (LRRK2) are a common cause of Parkinson's disease.
- LRRK2 phosphorylates Rab GTPases, affecting their interactions with downstream effectors.
- The dephosphorylation mechanisms counteracting LRRK2 signaling remain largely uncharacterized.
Purpose of the Study:
- To identify protein phosphatases that regulate LRRK2 signaling.
- To investigate the role of PPM1H in modulating LRRK2-mediated Rab phosphorylation.
- To explore PPM1H as a potential therapeutic target for Parkinson's disease.
Main Methods:
- siRNA screening of human protein phosphatases.
- Cellular assays in A549 cells to assess Rab phosphorylation levels.
- Biochemical studies using purified proteins and a substrate-trapping mutant of PPM1H.
- Immunofluorescence to determine PPM1H localization and effect on primary cilia.
Main Results:
- PPM1H was identified as a novel negative regulator of LRRK2 signaling.
- PPM1H specifically dephosphorylates LRRK2-phosphorylated Rab proteins, including Rab8A.
- PPM1H knockout enhanced Rab phosphorylation, while its overexpression suppressed it.
- PPM1H knockdown impaired primary cilia formation, mirroring effects of pathogenic LRRK2.
Conclusions:
- PPM1H acts as a key phosphatase counteracting LRRK2 activity by dephosphorylating Rab proteins.
- PPM1H's function in regulating Rab phosphorylation and primary cilia formation highlights its importance in cellular homeostasis.
- Modulating PPM1H activity presents a promising therapeutic avenue for Parkinson's disease.
More Related Videos
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
11:31Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amplifying Signals via Enzymatic Cascade
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The JAK-STAT Signaling Pathway